Article
The protean role of Val804Met RET mutation in thyroid neoplasms: An example of a "MEN2C" syndrome?
Pathology, research and practice - 1 Apr 2023
Miani Cesare, Locatello Luca Giovanni, Rugiu Maria Gabriella, Antonio Jamile Karina, Di Loreto Carla, Pegolo Enrico
Abstract excerpt
BACKGROUND: Val804Met RET is one of the most common genetic alterations in Multiple Endocrine Neoplasia 2 and is considered to confer only a moderate risk for familial medullary thyroid carcinoma (MTC). The associated phenotype can however be much more complex in some cases. METHODS: A clinical, genetic, and pathological analysis was conducted on a family cluster of thyroid neoplasms associated with Val804Met RET...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
